Tevogen Bio Holdings Inc. (TVGN) Analysis

We feel now is a pretty good time to analyse Tevogen Bio Holdings Inc.'s ( NASDAQ:TVGN ) business as it appears the...

Let’s break down Tevogen Bio Holdings ($TVGN), a clinical-stage immunotherapy company that’s been catching attention. Here’s the scoop on its recent moves, key price levels, and what’s driving the buzz: 🔹 What They Do: Tevogen focuses on off-the-shelf T cell therapies for infectious diseases, cancers, and neurological disorders. Their lead candidate, TVGN 489, is in Phase 1 for high-risk COVID-19 and Long COVID, with TVGN 920 (cervical cancer) and TVGN 601 (multiple sclerosis) in preclinical st...

Tevogen Bio Holdings (Nasdaq: TVGN) has received $1 million in non-dilutive funding from KRHP LLC to advance Tevogen.AI, its artificial intelligence-powered drug discovery program. This funding is part of a larger $10 million grant agreement, with $2 million already received in January 2025 and potential for an additional $8 million. The company plans to use the funds to enhance Tevogen.AI's capabilities following the recent patent publication of its machine learning technology for predicting i...